Michael Scolaro

Michael Scolaro

Oct 07, 2017

Group 6 Copy 220
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Are climate change and air pollution triggering cardiovascular disease?

Ongoing global climate change and air pollution emissions pose a major threat to cardiovascular health...

Can anle138b delay the onset of genetic prion disease?

Prions - infectious proteins - cause fatal, untreatable neurodegenerative diseases. A promising new compound...

A Modification to Homeopathic Drug Carcinosin

Cancer is linked to genetic mutations in hosts who are already genetically unique, which can make it seem...

Backer Badge Funded